💥New Chapter 11 Bankruptcy Filing - Humanigen Inc.💥

Biopharma company has (insider) stalking horse purchaser for a whopping $2mm.

On January 3, 2024, CA-based* Humanigen Inc. (the “debtor”)(OTCMKTS: $HGEN) kicked off the new year with a banger of a chapter 11 bankruptcy case; it is a cash-incinerating long-pre-revenue clinical-stage biopharma company with a pre-existing bankruptcy history (f/k/a Kalobios Pharmaceuticals Inc.)** and a plan to sell in chapter! Get pumped, y’all!!